{
    "clinical_study": {
        "@rank": "141326", 
        "arm_group": [
            {
                "arm_group_label": "Early discharge", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Standard discharge", 
                "arm_group_type": "Active Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of the study is to prove that early discharge (within 72 hours) in selected group of\n      patients  after myocardial infarction with elevations of ST-segment is feasible and safe"
        }, 
        "brief_title": "Verification of the Safety of Early Discharge in Patients After Acute ST-segment Myocardial Infarction", 
        "completion_date": {
            "#text": "May 2017", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Coronary Artery Disease", 
            "Acute Myocardial Infarction With ST-segment Elevation", 
            "Primary Percutaneous Coronary Intervention", 
            "Early Discharge"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Coronary Artery Disease", 
                "Myocardial Ischemia", 
                "Coronary Disease", 
                "Infarction", 
                "Myocardial Infarction"
            ]
        }, 
        "detailed_description": {
            "textblock": "The aim of the study is to prove\n\n        -  that early discharge (within 72 hours) in selected group of patients with low risk of\n           follow-up complications after myocardial infarction with elevations of ST-segment,\n           treated with primary percutaneous coronary intervention, is feasible and safe\n\n        -  that early discharge is \"non-inferior\" in comparison with the group of patients,\n           discharged in a standard way accordingly with present practice and physician\u00b4s decision\n           (usually 4th-7th day), thus it is not associated with higher incidence of complications\n           in 30th and 90th day after myocardial infarction"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Signed informed consent\n\n          -  Age \u226518 do  \u2264 75 years\n\n          -  Acute myocardial infarction with ST-segment elevation, treated with successful\n             percutaneous coronary intervention within 12 hours from the onset of symptoms\n\n          -  Left ventricle ejection fraction \u2265 45% by echocardiography\n\n          -  Single- or two-vessel disease (stenosis of major epicardial artery \u2265 70%)\n\n          -  Haemodynamic and rhythmic stability (Killip class I, no arrythmia requiring treatment\n             occurring > 2 hours after PCI)\n\n          -  Assumed good cooperation and social background\n\n        Exclusion Criteria:\n\n          -  Symptoms of residual ischemia\n\n          -  Significant comorbidities or abnormalities in paraclinical tests, requiring\n             additional evaluation within continuing hospitalization\n\n          -  Contraindication of dual antiplatelet therapy or need for anticoagulation therapy\n\n          -  Hihg risk of bleeding complications\n\n          -  Participation in other clinical study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "150", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 16, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02023983", 
            "org_study_id": "KN-11-2013"
        }, 
        "intervention": [
            {
                "arm_group_label": "Early discharge", 
                "description": "Early discharge (within 72 hours) of selected patients with low risk of complications after myocardial infarction with ST segment elevation, treated with successful percutaneous coronary intervention", 
                "intervention_name": "Early discharge", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Standard discharge", 
                "description": "Discharge after myocardial infarction with ST segment elevation in a standard way accordingly with present practice and physician\u00b4s decision (usually 4th-7th day)", 
                "intervention_name": "Standard discharge", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "ST-segment elevation myocardial infarction", 
            "Primary percutaneous coronary intervention", 
            "Low risk", 
            "Early discharge"
        ], 
        "lastchanged_date": "April 28, 2014", 
        "location": {
            "contact": {
                "email": "k.novobilsky@mnof.cz", 
                "last_name": "Kamil Novob\u00edlsk\u00fd, M.D.", 
                "phone": "+420 59 619 2660"
            }, 
            "contact_backup": {
                "email": "radim.kryza@mnof.cz", 
                "last_name": "Radim Kryza, M.D.", 
                "phone": "+420 59 619 4660"
            }, 
            "facility": {
                "address": {
                    "city": "Ostrava", 
                    "country": "Czech Republic", 
                    "zip": "728 80"
                }, 
                "name": "Municipal Hospital Ostrava"
            }, 
            "investigator": {
                "last_name": "Kamil Novob\u00edlsk\u00fd, M.D.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Czech Republic"
        }, 
        "number_of_arms": "2", 
        "official_title": "Official Title Verification of the Safety of Early Discharge (Within 72 Hours) in Low Risk Patients After Acute ST-segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention. Open Randomized Study.", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Czech Republic: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "\u2022 Composite of incidence of death, reinfarction, unstable angina pectoris, stroke, unplanned rehospitalization, repeat target vessel revascularization and stent thrombosis in 30 days after myocardial infarction (MI)", 
            "safety_issue": "Yes", 
            "time_frame": "30 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02023983"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Municipal Hospital Ostrava", 
            "investigator_full_name": "Kamil Novob\u00edlsk\u00fd", 
            "investigator_title": "M.D.", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Composite of incidence of death, reinfarction, unstable angina pectoris, stroke, unplanned rehospitalization, repeat target vessel revascularization and stent thrombosis in 90 days after MI", 
                "safety_issue": "Yes", 
                "time_frame": "90 days"
            }, 
            {
                "measure": "Complications associated with the puncture site requiring treatment in 30 days after myocardial infarction (MI)", 
                "safety_issue": "Yes", 
                "time_frame": "30 days"
            }
        ], 
        "source": "Municipal Hospital Ostrava", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Kamil Novob\u00edlsk\u00fd", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}